Trump orders DEA to allow some medical marijuana uses but keeps federal ban on recreational use intact

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The Trump administration is moving forward with plans to reclassify marijuana under Schedule III of the Controlled Substances Act, a move that will ease barriers to medical research into applications for cannabis and CBD products but will leave in place federal prohibitions on recreational use of the drug.

President Donald Trump announced the move during an Oval Office signing ceremony alongside cannabis industry representatives and Health and Human Services officials on Thursday.

“This action has been requested by American patients suffering from extreme pain, incurable diseases, aggressive cancers, seizure disorders, neurological problems and more, including numerous veterans with service related injuries and older Americans who live with chronic medical problems and severely degrade their quality of life,” he said.

A senior administration official told reporters that Trump’s order directs the Attorney General to expedite the rescheduling of marijuana to Schedule III under the Controlled Substance Act.

“The President is very focused on the potential medical benefits, and he has directed a common sense approach that will automatically will start working to improve the medical marijuana and CBD research to better inform patients and doctors. That’s the primary goal,” he said.

The official also said the White House Deputy Chief of Staff for Legislative Affairs would be directed to ensure Congress passes legislation to give Americans access to “appropriate full spectrum CBD products, while still restricting the sale and access to products that pose serious and potentially life threatening health risks.”

Trump’s intent, the official said, is to “ remove barriers to research.”

“The president has heard from so many people who have talked about the potential benefits of medical marijuana and CBD us, but he’s also heard from patients and and from doctors that there’s not enough research to inform medical guidelines, that many patients are using these products without talking to their doctor about them,” they added.

The official also stated that Trump is “very focused” on ensuring that “people that are using medical marijuana, especially in their in in their state regulated programs, have better research that can inform both them and their doctors.”

For more: Elrisala website and for social networking, you can follow us on Facebook
Source of information and images “independent”“